A genome-wide screen for variants influencing certolizumab pegol response in a moderate to severe rheumatoid arthritis population

White, I. R., Kleinstein, S. E., Praet, C., Chamberlain, C., McHale, D., Maia, J. M., Xie, P., Goldstein, D. B., Urban, T. J., & Shea, P. R. (2022). A genome-wide screen for variants influencing certolizumab pegol response in a moderate to severe rheumatoid arthritis population. PLOS ONE, 17(4), e0261165. https://doi.org/10.1371/journal.pone.0261165
Authors:
Ian R White
Sarah E Kleinstein
Christophe Praet
Chris Chamberlain
Duncan McHale
Jessica M Maia
Pingxing Xie
David B Goldstein
Thomas J Urban
Patrick R Shea
Affiliated Authors:
Sarah E Kleinstein
Jessica M Maia
Pingxing Xie
David B Goldstein
Patrick R Shea
Columbia Affiliation:
Publication Type:
Article
Unique ID:
10.1371/journal.pone.0261165
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: